C12Y 305/00
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds
Official title: Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
C12Y305/00 (Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds) appears on 1,051 US grants and 2,131 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1,051
- Published applications
- 2,131
- Assignees
- 869
- Inventors
- 4,083
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 24 | 1 |
| 2002 | 16 | 15 |
| 2003 | 9 | 16 |
| 2004 | 10 | 24 |
| 2005 | 2 | 16 |
| 2006 | 6 | 21 |
| 2007 | 7 | 14 |
| 2008 | 15 | 28 |
| 2009 | 5 | 35 |
| 2010 | 15 | 40 |
| 2011 | 27 | 30 |
| 2012 | 22 | 38 |
| 2013 | 19 | 43 |
| 2014 | 35 | 52 |
| 2015 | 35 | 74 |
| 2016 | 35 | 90 |
| 2017 | 48 | 105 |
| 2018 | 58 | 107 |
| 2019 | 71 | 118 |
| 2020 | 82 | 142 |
| 2021 | 70 | 148 |
| 2022 | 73 | 196 |
| 2023 | 77 | 179 |
| 2024 | 78 | 212 |
| 2025 | 102 | 210 |
| 2026 | 71 | 177 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for modulating RNA splicing by inducing base mutation at splice site or base substitution in polypyrimidine region6 Oct 2026US 12,753,420 B2Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
- DCAS13-mediated therapeutic RNA base editing for in vivo gene therapy29 Sep 2026US 12,746,295 B2University of Massachusetts
- Adenine deaminases and compositions, systems, and methods thereof29 Sep 2026US 12,747,436 B2Profluent Bio Inc.
- Compositions comprising a CAS12I polypeptide and uses thereof29 Sep 2026US 12,747,457 B2Arbor Biotechnologies, Inc.
- Arginase 1 binders for inhibiting Arginase 1 activity15 Sep 2026US 12,735,506 B2Merck Sharp & Dohme Corp.
- Base editing approaches to treat abca4-associated stargardt disease8 Oct 2026US 2026/0306670 A1Massachusetts Eye and Ear Infirmary
- Cas-embedded Cytidine Deaminase Ribonucleoprotein Complexes having Improved Base Editing Specificity and Efficiency8 Oct 2026US 2026/0308553 A1University of Massachusetts
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- System, Kit, and Method for Continuous Directed Evolution8 Oct 2026US 2026/0308569 A1The Board of Trustees of the University of Illinois
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
Most cited
By later US patents
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination531US 6,117,679 AMaxygen, Inc. · 2000
- Methods of shuffling polynucleotides373US 6,132,970 AMaxygen, Inc. · 2000